v3 Template
L

Lomond Therapeutics Holdings, Inc.

Biotechnology / Pharmaceuticals ~150 employees
Founded
--
Employees (Est.)
~150
10 leaders known
Total Funding
$20.0M
Funding Rounds
1
Last Funding
2025-03-28

About Lomond Therapeutics Holdings, Inc.

Lomond Therapeutics is a small molecule oncology drug discovery company focused on defeating cancer. As a precision hematology company, it is a development stage spinout from Eilean Therapeutics, targeting resistant mutations in hematological and solid cancer malignancies with first and best-in-class medicines.

Products & Services

Lonitoclax:A selective BCL-2 inhibitor with best-in-class selectivity versus BCL-XL and no CYP 3A4 liability, currently in ongoing clinical studies.

Specialties

Precision Hematology Oncology Drug Discovery Targeting Resistant Mutations in Hematological and Solid Cancers

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Private Placement
T: -
FT: Private Placement 		A: 20000000
MR: -
FA: $20 million
FAN: 20000000 		D: 2025-03-28
FD: 2025-03-28 		2 investors
Private Placement Latest
2025-03-28
$20.0M
2 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

John C Byrd

CHAIRMAN

LinkedIn (Pro only)
R

Ruben Abagyan

Professor

I

Iain Dukes

CEO

LinkedIn (Pro only)
E

Eddie Wang Rodriguez

GENERAL PARTNER

N

Nikolay Savchuk

COO

C

Carl Gordon

GENERAL PARTNER

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Lomond Therapeutics Holdings, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Pharmaceuticals
Company Size
~150 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro